Stamos Capital Partners, L.P. Novo Nordisk A S Transaction History
Stamos Capital Partners, L.P.
- $429 Million
- Q1 2024
A detailed history of Stamos Capital Partners, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Stamos Capital Partners, L.P. holds 3,880 shares of NVO stock, worth $553,831. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,880
Previous 5,070
23.47%
Holding current value
$553,831
Previous $524,000
4.96%
% of portfolio
0.12%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,865Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.01 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.96 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.69 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $322B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...